tiprankstipranks
Trending News
More News >
ANGLE plc (GB:CLBX)
LSE:CLBX

ANGLE plc (CLBX) Price & Analysis

Compare
37 Followers

CLBX Stock Chart & Stats

Currently, no data available
Please return soon. This page is being updated.

ANGLE plc News

CLBX FAQ

What was ANGLE plc’s price range in the past 12 months?
ANGLE plc lowest share price was 1.00p and its highest was 17.45p in the past 12 months.
    What is ANGLE plc’s market cap?
    ANGLE plc’s market cap is £11.96M.
      When is ANGLE plc’s upcoming earnings report date?
      The company’s upcoming earnings report date is not yet available.
      How were ANGLE plc’s earnings last quarter?
      Currently, no data Available
      Is ANGLE plc overvalued?
      According to Wall Street analysts ANGLE plc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does ANGLE plc pay dividends?
        ANGLE plc does not currently pay dividends.
        What is ANGLE plc’s EPS estimate?
        ANGLE plc’s EPS estimate for its next earnings report is not yet available.
        How many shares outstanding does ANGLE plc have?
        ANGLE plc has 1,136,402,700 shares outstanding.
          What happened to ANGLE plc’s price movement after its last earnings report?
          Currently, no data Available
          Which hedge fund is a major shareholder of ANGLE plc?
          Currently, no hedge funds are holding shares in GB:CLBX
          What is the TipRanks Smart Score and how is it calculated?
          Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

            Company Description

            ANGLE plc

            ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.
            Popular Stocks